Lorlatini

Lorlatini uses and dosage

Lorlatini (Lorlatinib), generic Lorbrena is a prescription medicine that is used to treat metastatic non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Lorlatinib is used in patients who have already received alectinib, ceritinib or both crizotinib and at least 1 other medicine to treat NSCLC that is caused by the ALK gene. Lorlatini manufactured by TLPH Pharma Ltd. in Laos. Lorlatinib has to take orally once a day with or without food.

Lorlatini side effects

The most common adverse reactions of Lorlatinib are: Tiredness, constipation, nausea / vomiting, diarrhea, numbness/ tingling of arms/ legs, swelling ankles/ feet/ hands, dizziness, headache, trouble sleeping, weight gain, muscle/ joint pain, or vision changes.

Made by

TLPH Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.